Table 1: Patients’ characteristics.

Background data

Patients (n = 14)

Age (years)

62.1 ± 7.2

International staging system

 

I

4

II

4

III

6

Monoclonal protein

 

IgG

10

IgA

4

Concurrent chemotherapy

 

Absent

0

Present

14

Months since diagnosis

9 [0-396]

Time between examinations (months)

9.4 ± 8.6

Use of ZA between examinations

 

Absent

7

Present

7

Response to chemotherapy

 

CR

0

PR (VGPR)

10 (1)

SD

3

PD

1

 

Data are presented as means ± SD or median [range], as appropriate. ZA: Zoledronic Acid; CR: Complete Remission; PR: Partial Response; VGPR: Very Good PR; SD: Stable Disease; PD: Progressive Disease